Welcome to the RfB

This website provides all information concerning the accredited EQA schemes of the RfB:

Our online supply for your lab

News

  1. New survey: Dermatophytes, genome detection


    On November 25, 2022, changes to the guidelines of the German Medical Association for the quality assurance of laboratory medical examinations (Rili-BÄK) came into force through the announcement in the German Medical Journal. One major change is the mandatory participation for the genome detection of dermatophytes from 25th November 2024.

    The Reference Institute for Bioanalytics (RfB) is offering a corresponding dermatophyte proficiency testing scheme (DermPCR) in October 2024.

    Participation in this survey is free of charge for registered participants. Only the shipping costs for the samples will be charged. You can register via your participant account at www.rfb.bio. Please note that the registration deadline is 12th August 2024. The trial period runs from 7th October 2024 to 19th October 2024.

    We look forward to your participation.

  2. IgG subclass determination in IG4/24

    Starting with the survey IG4/24 you have the possibility to perform the IgG subclass determination (IgG1, IgG2, IgG3, IgG4).

  3. AAL 2024 - 23rd Annual Conference of the Association of Accredited Laboratories in Düsseldorf

    On September 13th and 14th, we are co-hosting the 23rd AAL conference in Düsseldorf. We are excited to offer a diverse program featuring engaging workshops, panel discussions, and practical case studies.

    This conference provides an excellent opportunity to network with colleagues, gain new insights, and establish valuable connections. We look forward to two inspiring days filled with engaging discussions and the chance to share valuable experiences.

    Join us in Düsseldorf – we look forward to your attendance! For more information, please visit: https://aal-tagung.de/

  4. EurA1cTrial 2022

    EurA1c, the trial exploring the effectiveness of HbA1c tests across various countries and manufacturers, was conducted for the seventh time in 2022. Over 4,000 laboratories in 22 countries participated. The report is now available on our website.

Latest evaluations

  1. 24.07.24

    BorrBimm1/24 B. burgdorferi

  2. 24.07.24

    GH3/24 Hb A1c

  3. 24.07.24

    GL3/24 Glucose (wet, dry)

  4. 24.07.24

    KU3/24 Clin chem in urine

  5. 24.07.24

    KUST3/24 Pregnancy test in ur

  6. 24.07.24

    MRSAscre1/24 MRSA Screening

  7. 24.07.24

    RoetLimm1/24 Rubella virus

  8. 24.07.24

    ToxoGimm1/24 T. gondii

  9. 24.07.24

    TrepPimm1/24 Trep. pallidum

  10. 24.07.24

    VariAimm1/24 several antibodys

  11. 24.07.24

    ZZ1/24 csf cytospin analysi

  12. 23.07.24

    KL3/24 Clin chem in CSF

  13. 11.07.24

    ParasitB1/24 Parasiten im Blut

  14. 11.07.24

    ParasitS1/24 Parasiten im Stuhl

Office
Friesdorfer Straße 153
53175 Bonn

Phone: +49 2 28 / 92 68 95 - 0
Fax: +49 2 28 / 92 68 95 - 29

Internet: www.rfb.bio
E-mail: info@spmd-rfb.de

Logo DAAKS - Deutscher Akkreditierungs Rat

Icon PDFDownload:
certificate of accreditation